Publications

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance

Grossmann, V., Kohlmann, A., Eder, C. et al.

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic malignancy characterized by myeloproliferative or myelodysplastic features. Factors predicting the course of disease are poorly understood and rely on clinical parameters such as anemia, splenomegaly or leukocytosis.

Citation

Grossmann, V., Kohlmann, A., Eder, C. et al. "Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance" Leukemia (2011): 877–9